Trends in Collaborative Drug Therapy Management

Karen E. Koch, PharmD

In This Article


Although there are a limited number of studies, it appears that physicians, pharmacists, and patients are satisfied with CDTM. In 1996, Fuller and co-workers[41] surveyed the physicians and pharmacists involved in CDTM in Washington state and found that most prescribers (98%) and most pharmacists (95%) were satisfied with protocol arrangements. At the Cedars-Sinai cardiovascular risk-reduction clinic, the majority of high-risk patients achieved their goal low-density lipoprotein cholesterol level, and most of them were satisfied with the pharmacist-managed clinic.[24]

Pharmacists still have a number of issues to address regarding CDTM; namely, training and credentialing, legislative and regulatory support, and payment/compensation. It will take a while to work through these issues, but there is great momentum. Pharmacists must not only document the outcomes of their CDTM practice but also place a pharmacoeconomic value on these services.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.